论文部分内容阅读
Aims: To assess visual function, vision related quality of life (VR-QOL), and general health related quality of life (HRQOL) in intermediate uveitis (IU). Methods: VR-QOL and HR-QOL were evaluated in 42 patientswith IUusing theVCM1 and SF- 36 questionnaires, respectively. LogMAR visual acuity (VA), Pelli-Robson contrast sensitivity (CS), Farnsworth-Munsell 100 hue colour vision (CV), and Estermann visual field (VF) were recorded monocularly and binocularly. Results: Median (interquartile range) visual acuity (VA) and CS of 72 affected eyes were 0.1 (0.015- 0.3) and 1.55 (1.35- 1.65), respectively. 9.5% of patients had a VCM1 score of more than 2.0, indicating “ more than a little” concern over vision. Worse eye VA (p=0.045) and CS (p=0.042) were predictive of a VCM1 score ofmore than 2.0 independently of age, sex, uveitis duration, laterality and activity, systemic uveitis therapy, and medical co-morbidity. The physical and mental component summary scores of the SF- 36 were significantly worse in those who reported significant impairment of vision on the VCM1 than those who did not. Conclusions: The majority of patients with IU maintain good visual function and quality of life. VRQOL impairment in IU correlates with vision in the worse eye and is associated with impaired HR-QOL.
Aims: To assess visual function, vision related quality of life (VR-QOL), and general health related quality of life (HRQOL) in intermediate uveitis (IU). Methods: VR-QOL and HR-QOL were evaluated in 42 patients with IUusing TheVCM1 and SF-36 questionnaires, respectively. LogMAR visual acuity (VA), Pelli-Robson contrast sensitivity (CS), Farnsworth-Munsell 100 hue color vision (CV), and Estermann visual field (VF) were recorded monocularly and binocularly. : 9.5% of patients had a VCM1 score of more than 2.0, indicating “more.” Median (interquartile range) visual acuity (VA) and CS of 72 affected eyes were 0.1 (0.015- 0.3) and 1.55 (1.35- 1.65) Worse eye VA (p = 0.045) and CS (p = 0.042) were predictive of a VCM1 score of more than 2.0 independently of age, sex, uveitis duration, laterality and activity, systemic uveitis therapy, and medical co-morbidity. The physical and mental component summary scores of the SF-36 were signifi cantly worse in those who reported significant impairment of vision on the VCM1 than those who did not. Conclusions: The majority of patients with IU maintain good visual function and quality of life. VRQOL impairment in IU correlates with vision in the worse eye and is associated with impaired HR-QOL.